1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease—2020 report. Accessed March 27, 2020. https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf.
Google Scholar2. National Institutes of Health . Morbidity and mortality: 2012 chart book on cardiovascular, lung, and blood diseases. Accessed August 3, 2021. https://www.nhlbi.nih.gov/files/docs/research/2012_ChartBook_508.pdf.
Google Scholar3. National Center for Health Statistics . Health, United States, 2018. Accessed August 3, 2021. https://www.cdc.gov/nchs/data/hus/hus18.pdf.
Google Scholar4. Zafari, Z, Li, S, Eakin, MN, Bellanger, M, Reed, RM. Projecting long-term health and economic burden of COPD in the United States. Chest. 2021;159(4):1400-1410. doi:10.1016/j.chest.2020.09.255.
Google Scholar | Crossref | Medline5. Zarowitz, BJ, O’Shea, T. Chronic obstructive pulmonary disease: prevalence, characteristics, and pharmacologic treatment in nursing home residents with cognitive impairment. J Manag Care Pharm. 2012;18(8):598-606. doi:10.18553/jmcp.2012.18.8.598.
Google Scholar | Crossref | Medline6. Gravenstein, S, Davidson, HE, Taljaard, M, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. Lancet Respir Med. 2017;5(9):738-746. doi:10.1016/S2213-2600(17)30235-7.
Google Scholar | Crossref | Medline7. Pleasants, RA, Radlowski, PA, Davidson, HE. Optimizing drug therapies in patients with COPD in the US nursing home setting. Drugs Aging. 2019;36(8):733-745. doi:10.1007/s40266-019-00680-x.
Google Scholar | Crossref | Medline8. Simoni-Wastila, L, Blanchette, CM, Qian, J, et al. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities. Am J Geriatr Pharmacother. 2009;7(5):262-270. doi:10.1016/j.amjopharm.2009.11.003.
Google Scholar | Crossref | Medline9. Mahler, DA. The role of inspiratory flow in selection and use of inhaled therapy for patients with chronic obstructive pulmonary disease. Respir Med. 2020;161:105857. doi:10.1016/j.rmed.2019.105857.
Google Scholar | Crossref | Medline10. AMDA -The Society for Post-Acute and Long-Term Care Medicine . Clinical practice guidelines: COPD management in the post-acute and long-term care setting. Accessed March 27, 2020. https://paltc.org/product-store/copd-management-cpg-pocket-guide.
Google Scholar11. Tashkin, DP, Cooper, CB. The role of long-acting bronchodilators in the management of stable COPD. Chest. 2004;125(1):249-259. doi:10.1378/chest.125.1.249.
Google Scholar | Crossref | Medline12. Gray, SL, Williams, DM, Pulliam, CC, Sirgo, MA, Bishop, AL, Donohue, JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med. 1996;156(9):984-988. doi:10.1001/archinte.1996.00440090084008.
Google Scholar | Crossref | Medline13. Allen, SC, Jain, M, Ragab, S, Malik, N. Acquisition and short-term retention of inhaler techniques require intact executive function in elderly subjects. Age Ageing. 2003;32(3):299-302. doi:10.1093/ageing/32.3.299.
Google Scholar | Crossref | Medline14. Barrons, R, Wheeler, J, Woods, JA. Opportunities for inhaler device selection in elderly patients with asthma or COPD. Patient Intell. 2015;7:53-65. doi:10.2147/PI.S61200.
Google Scholar | Crossref15. Suarez-Barcelo, M, Micca, JL, Clackum, S, Ferguson, GT. Chronic obstructive pulmonary disease in the long-term care setting: current practices, challenges, and unmet needs. Curr Opin Pulm Med. 2017;23 Suppl 1:S1-S28. doi:10.1097/MCP.0000000000000416.
Google Scholar | Crossref16. Centers for Medicare and Medicaid Services . MDS 3.0 frequency report. Accessed April 23, 2020. https://www.cms.gov/Research-Statistics-Data-and-Systems/Computer-Data-and-Systems/Minimum-Data-Set-3-0-Public-Reports/Minimum-Data-Set-3-0-Frequency-Report.
Google Scholar17. Jones, PW, Tabberer, M, Chen, WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med. 2011;11:42. doi:10.1186/1471-2466-11-42.
Google Scholar | Crossref | Medline | ISI18. Wheaton, AG, Ford, ES, Cunningham, TJ, Croft, JB. Chronic obstructive pulmonary disease, hospital visits, and comorbidities: National Survey of Residential Care Facilities, 2010. J Aging Health. 2015;27(3):480-499. doi:10.1177/0898264314552419.
Google Scholar | SAGE Journals | ISI19. Jones, A, Feeny, D, Costa, AP. Longitudinal construct validity of the Minimum Data Set health status index. Health Qual Life Outcomes. 2018;16(1):102. doi:10.1186/s12955-018-0932-9.
Google Scholar | Crossref | Medline20. Thomas, KS, Ogarek, JA, Teno, JM, Gozalo, PL, Mor, V. Development and validation of the nursing home Minimum Data Set 3.0 Mortality Risk Score (MRS3). J Gerontol A Biol Sci Med Sci. 2019;74(2):219-225. doi:10.1093/gerona/gly044.
Google Scholar | Crossref | Medline21. Macaulay, D, Sun, SX, Sorg, RA, et al. Development and validation of a claims-based prediction model for COPD severity. Respir Med. 2013;107(10):1568-1577. doi:10.1016/j.rmed.2013.05.012.
Google Scholar | Crossref | Medline22. Davidson, HE, Radlowski, PA, Han, L, et al. Clinical characterization of nursing home residents with chronic obstructive pulmonary disease. Sr Care Pharm. 2021;36(5):248-257. doi:10.4140/TCP.n.2021.248.
Google Scholar | Crossref | Medline23. Kroenke, K, Spitzer, RL, Williams, JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.2001.016009606.x.
Google Scholar | Crossref | Medline | ISI24. Morris, JN, Fries, BE, Morris, SA. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci. 1999;54(11):M546-53. doi:10.1093/gerona/54.11.m546.
Google Scholar | Crossref25. Garten, R, Blanton, L, Abd Elal, AI, et al. Update: influenza activity in the United States during the 2017–18 season and composition of the 2018–19 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2018;67(22):634. doi:10.15585/mmwr.mm6722a4.
Google Scholar | Crossref | Medline26. Cohen, J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. New York, NY: Lawrence Erlbaum; 1988. doi:10.4324/9780203771587.
Google Scholar | Crossref27. Steyerberg, EW. Validation in prediction research: the waste by data splitting. J Clin Epidemiol. 2018;103:131-133. doi:10.1016/j.jclinepi.2018.07.010.
Google Scholar | Crossref | Medline28. Patel, M, Steinberg, K, Suarez-Barcelo, M, Saffel, D, Foley, R, Worz, C. Chronic obstructive pulmonary disease in post-acute/long-term care settings: seizing opportunities to individualize treatment and device selection. J Am Med Dir Assoc. 2017; X18(6):553.e17-553.e22. doi:10.1016/j.jamda.2017.03.020.
Google Scholar | Crossref29. Morley, JE. Chronic obstructive pulmonary disease: a disease of older persons. J Am Med Dir Assoc. 2014;15(3):151-153. doi:10.1016/j.jamda.2013.12.078.
Google Scholar | Crossref | Medline30. Davis, E, Coover, K, Morrow, L, Malesker, M. Differentiating the treatment of asthma and chronic obstructive pulmonary disease in the elderly patient. Consult Pharm. 2012;27(9):650-659. doi:10.4140/TCP.n.2012.650.
Google Scholar | Crossref | Medline